Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 2, Issue 9
May 8 2018
Issue Cover

Table of Contents

STIMULUS REPORT

CIP2A- and SETBP1-mediated PP2A inhibition reveals AKT S473 phosphorylation to be a new biomarker in AML
Claire M. Lucas,Laura J. Scott,Natasha Carmell,Alison K. Holcroft,Robert K. Hills,Alan K. Burnett,Richard E. Clark
View Articletitled, CIP2A- and SETBP1-mediated PP2A inhibition reveals AKT S473 phosphorylation to be a new biomarker in AML
Supplemental data
Profilin 1–mediated cytoskeletal rearrangements regulate integrin function in mouse platelets
Simon Stritt,Inga Birkholz,Sarah Beck,Simona Sorrentino,K. Tanuj Sapra,Julien Viaud,Johannes Heck,Frédérique Gaits-Iacovoni,Harald Schulze,Xiaoping Du,John H. Hartwig,Attila Braun,Markus Bender,Ohad Medalia,Bernhard Nieswandt
View Articletitled, Profilin 1–mediated cytoskeletal rearrangements regulate integrin function in mouse platelets
Supplemental data

CLINICAL TRIALS AND OBSERVATIONS

Randomized phase 2 trial of monthly vitamin D to prevent respiratory complications in children with sickle cell disease
Clinical Trials & Observations
Margaret T. Lee,Meyer Kattan,Ilene Fennoy,Stephen M. Arpadi,Rachel L. Miller,Serge Cremers,Donald J. McMahon,Jeri W. Nieves,Gary M. Brittenham
View Articletitled, Randomized phase 2 trial of monthly vitamin D to prevent respiratory complications in children with sickle cell disease
Supplemental data
Prognostic significance of bone marrow abnormalities in the appendicular skeleton of patients with multiple myeloma
Clinical Trials & Observations
Kosei Matsue,Hiroki Kobayashi,Yuya Matsue,Yoshiaki Abe,Kentaro Narita,Akihiro Kitadate,Masami Takeuchi
View Articletitled, Prognostic significance of bone marrow abnormalities in the appendicular skeleton of patients with multiple myeloma
Supplemental data

GENE THERAPY

Rapid immune reconstitution of SCID-X1 canines after G-CSF/AMD3100 mobilization and in vivo gene therapy
Olivier Humbert,Frieda Chan,Yogendra S. Rajawat,Troy R. Torgerson,Christopher R. Burtner,Nicholas W. Hubbard,Daniel Humphrys,Zachary K. Norgaard,Patricia O’Donnell,Jennifer E. Adair,Grant D. Trobridge,Andrew M. Scharenberg,Peter J. Felsburg,David J. Rawlings,Hans-Peter Kiem
View Articletitled, Rapid immune reconstitution of SCID-X1 canines after G-CSF/AMD3100 mobilization and in vivo gene therapy
Supplemental data

HEMATOPOIESIS AND STEM CELLS

Sustained clonal hematopoiesis by HLA-lacking hematopoietic stem cells without driver mutations in aplastic anemia
Clinical Trials & Observations
Tatsuya Imi,Takamasa Katagiri,Kazuyoshi Hosomichi,Yoshitaka Zaimoku,Viet Hoang Nguyen,Noriharu Nakagawa,Atsushi Tajima,Tetsuichi Yoshizato,Seishi Ogawa,Shinji Nakao
View Articletitled, Sustained clonal hematopoiesis by HLA-lacking hematopoietic stem cells without driver mutations in aplastic anemia
Supplemental data

THROMBOSIS AND HEMOSTASIS

Abnormal clotting of the intrinsic/contact pathway in Alzheimer disease patients is related to cognitive ability
Clinical Trials & Observations
Georgette L. Suidan,Pradeep K. Singh,Sunita Patel-Hett,Zu-Lin Chen,Dmitri Volfson,Hitomi Yamamoto-Imoto,Erin H. Norris,Robert D. Bell,Sidney Strickland
View Articletitled, Abnormal clotting of the intrinsic/contact pathway in Alzheimer disease patients is related to cognitive ability
Supplemental data
Complement C5 but not C3 is expendable for tissue factor activation by cofactor-independent antiphospholipid antibodies
Nadine Müller-Calleja,Svenja Ritter,Anne Hollerbach,Tanja Falter,Karl J. Lackner,Wolfram Ruf
View Articletitled, Complement C5 but not C3 is expendable for tissue factor activation by cofactor-independent antiphospholipid antibodies
Analysis of MCFD2- and LMAN1-deficient mice demonstrates distinct functions in vivo
Min Zhu,Chunlei Zheng,Wei Wei,Lesley Everett,David Ginsburg,Bin Zhang
View Articletitled, Analysis of MCFD2- and LMAN1-deficient mice demonstrates distinct functions in vivo

TRANSPLANTATION

Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplants
Clinical Trials & Observations
Anita J. Kumar,Soyoung Kim,Michael T. Hemmer,Mukta Arora,Stephen R. Spellman,Joseph A. Pidala,Daniel R. Couriel,Amin M. Alousi,Mahmoud D. Aljurf,Jean-Yves Cahn,Mitchell S. Cairo,Corey S. Cutler,Shatha Farhan,Usama Gergis,Gregory A. Hale,Shahrukh K. Hashmi,Yoshihiro Inamoto,Rammurti T. Kamble,Mohamed A. Kharfan-Dabaja,Margaret L. MacMillan,David I. Marks,Hideki Nakasone,Maxim Norkin,Muna Qayed,Olle Ringden,Harry C. Schouten,Kirk R. Schultz,Melhem M. Solh,Takanori Teshima,Alvaro Urbano-Ispizua,Leo F. Verdonck,Robert Peter Gale,Betty K. Hamilton,Navneet S. Majhail,Alison W. Loren
View Articletitled, Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplants

ERRATUM

Fanciullino R, Farnault L, Donnette M, et al. CDA as a predictive marker for life-threatening toxicities in patients with AML treated with cytarabine. Blood Adv. 2018;2(5):462-469.
View Articletitled, Fanciullino R, Farnault L, Donnette M, et al. CDA as a predictive marker for life-threatening toxicities in patients with AML treated with cytarabine. <em>Blood Adv</em>. 2018;2(5):462-469.
All Issues

Advertisement intended for health care professionals

Risk of T-cell malignancy after CAR T-cell therapy in children, adolescents, and young adults
Blockage of BCL-XL overcomes venetoclax resistance across BCL2+ lymphoid malignancies irrespective of BIM status
A research center’s experience of T-cell–redirecting therapies in triple-class refractory multiple myeloma
The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas
Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals